REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal

被引：0

作者：

S. Batista

C. C. Nunes

J. J. Cerqueira

Ana Martins Silva

J. Correia de Sá

J. Ferreira

M. T. Mendonça

J. Pinheiro

V. Salgado

A. S. Correia

J. Sequeira

A. Costa

L. Sousa

机构：

[1] Centro Hospitalar e Universitário de Coimbra,School of Medicine

[2] Hospital de Braga,Unidade Multidisciplinar Investigação Biomédica, Instituto Ciências Biomédicas Abel Salazar

[3] University of Minho,Centro Hospitalar Lisboa Norte E.P.E.

[4] Centro Hospitalar Universitário do Porto,Centro Hospitalar de Lisboa Ocidental E.P.E.

[5] Universidade do Porto,Centro Hospitalar Universitário de Lisboa Central E.P.E.

[6] Hospital de Santa Maria,undefined

[7] Centro Hospitalar São João,undefined

[8] Centro Hospitalar Vila Nova Gaia,undefined

[9] Hospital Prof. Doutor Fernando Fonseca E.P.E.,undefined

[10] Hospital de Egas Moniz,undefined

[11] Hospital Santo António dos Capuchos,undefined

[12] Novartis Farma,undefined

来源：

Neurological Sciences | 2021年 / 42卷

关键词：

Relapsing-remitting multiple sclerosis; Real-world study; Fingolimod; ARR; EDSS; Safety;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1995 / 2003

页数：8

共 50 条

[1] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
Batista, S.
Nunes, C. C.
Cerqueira, J. J.
Martins Silva, Ana
Correia de Sa, J.
Ferreira, J.
Mendonca, M. T.
Pinheiro, J.
Salgado, V.
Correia, A. S.
Sequeira, J.
Costa, A.
Sousa, L.
[J]. NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1995 - 2003
[2] Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
S. Batista
C. C. Nunes
J. J. Cerqueira
Ana Martins Silva
J. Correia de Sá
J. Ferreira
M. T. Mendonça
J. Pinheiro
V. Salgado
A. S. Correia
J. Sequeira
A. Costa
L. Sousa
[J]. Neurological Sciences, 2021, 42 : 767 - 767
[3] The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
Izquierdo, Guillermo
Damas, Fatima
Dolores Paramo, Maria
Luis Ruiz-Pena, Juan
Navarro, Guillermo
[J]. PLOS ONE, 2017, 12 (04):
[4] Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
Comi, Giancarlo
Pozzilli, Carlo
Morra, Vincenzo Brescia
Bertolotto, Antonio
Sangalli, Francesca
Prosperini, Luca
Carotenuto, Antonio
Iaffaldano, Pietro
Capobianco, Marco
Colombo, Delia
Nica, Mihaela
Rizzoli, Sara
Trojano, Maria
[J]. NEUROLOGICAL SCIENCES, 2020, 41 (10) : 2843 - 2851
[5] Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
Giancarlo Comi
Carlo Pozzilli
Vincenzo Brescia Morra
Antonio Bertolotto
Francesca Sangalli
Luca Prosperini
Antonio Carotenuto
Pietro Iaffaldano
Marco Capobianco
Delia Colombo
Mihaela Nica
Sara Rizzoli
Maria Trojano
[J]. Neurological Sciences, 2020, 41 : 2843 - 2851
[6] Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis
Walczak, Agata
Kurkowska-Jastrzebska, Iwona
Zakrzewska-Pniewska, Beata
Dorobek, Malgorzata
Brola, Waldemar
Zajdel, Radoslaw
Bartosik-Psujek, Halina
Stasiolek, Mariusz
Kulakowska, Alma
Rusek, Stanislaw
Tutaj, Andrzej
Glabinski, Andrzej
Wlodek, Agata
Kochanowski, Jan
Ciach, Agnieszka
Siger, Malgorzata
Kurowska, Katarzyna
Wicha, Wojciech
Nojszewska, Monika
Podlecka-Pietowska, Aleksandra
Czajka, Anna
Kapica-Topczewska, Katarzyna
Bielecki, Bartosz
Maciagowska-Terela, Marzena
Stepien, Adam
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 184
[7] Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis
Walczak, A.
Kurkowska-Jastrzebska, I.
Zakrzewska-Pniewska, B.
Dorobek, M.
Brola, W.
Zajdel, R.
Bartosik-Psujek, H.
Kulakowska, A.
Rusek, S.
Tutaj, A.
Glabinski, A.
Wlodek, A.
Kochanowski, J.
Stepien, A.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 328 - 328
[8] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal (September, 10.1007/s10072-020-04726-6, 2020)
Batista, S.
Nunes, C. C.
Cerqueira, J. J.
Silva, Ana Martins
de Sa, J. Correia
Ferreira, J.
Mendonca, M. T.
Pinheiro, J.
Salgado, V.
Correia, A. S.
Sequeira, J.
Costa, A.
Sousa, L.
[J]. NEUROLOGICAL SCIENCES, 2021, 42 (02) : 767 - 767
[9] The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study
Curti, Erica
Tsantes, Elena
Baldi, Eleonora
Caniatti, Luisa Maria
Ferraro, Diana
Sola, Patrizia
Granella, Franco
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 146 - 152
[10] Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
Barrero, Francisco
Mallada-Frechin, Javier
Luisa Martinez-Gines, Maria
Eugenia Marzo, Maria
Meca-Lallana, Virginia
Izquierdo, Guillermo
Ramon Ara, Jose
Oreja-Guevare, Celia
Meca-Lallana, Jose
Forero, Lucia
Sanchez-Veram, Irene
Jose Moreno, Maria
[J]. PLOS ONE, 2020, 15 (04):

← 1 2 3 4 5 →